Previous
Pause
Siguiente
Skip to Navigation
↓
Congresos
Año
Año
Año
-Año
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Investigador
Todos
cristinapozo
dgomez
usuario_prueba
Almeida e Silva, Filomena Augusta
Amorín , Ricardo
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Castro Barrigón, Alberto
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
DeMiguel , Daniel
Espina Cadena, Laura
Fernandez Antoran, David
Ferrio Díaz, Juan Pedro
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Martínez-Padilla , Jesús
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Título
Título
Año
1. Genetic deficit of KCa3.1 channels protects against edema and pulmonary circulatory collapse caused by TRPV4 activation. 2. Characterization of monocyte/macrophage KCa3.1 channels in Gaucher’s Disease. 3. New negative-gating modulators of KCa2 and KCa
2015
1. Role of SK3 channels in erectile function in mice 2. Genetic deficit of KCa3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation
2015
Cardiovascular alterations in KCa3.1/KCa2.3-deficient mice and after acute treatment with KCa3.1/KCa2.3 activators.
2012
Defective Function of KCa3. 1 Channels in Lysosomal Storage Disorders
2017
DEFICIENCY OF MONOCYTE/MACROPHAGE KCA3.1-FUNCTIONS IN TYPE-1/3 GAUCHER DISEASE
2016
Design and development of novel KCa modulators and utilities in neurological disease
2014
Innovative negative gating modulators of kca2/3 potassium channels as new pharmacological tools
2014
Invited Talk: Emerging pathogenic roles of KCa3.1 channels in skin disease.
2018
Ion channels and regulation of vascular function, tr(i)ps to EDHF.
2012
KCa3.1 channel in endothelial/epithelial cell signaling and as drug target
2017
KCa3.1-overexpression in murine intestinal epithelium impairs duodenal motility
2018
KCa3.1-overexpression in skin causes pruritic eczema and epidermal hyperplasi
2019
LA SOBRE-EXPRESIÓN CONDICIONAL DEL CANAL KCa3.1 ALTERA SEVERAMENTE LA MOTILIDAD INTESTINAL EN RATÓN
2017
Lysosomal Storage Disorders as Group Representative
2017
New treatment strategies for Multiple Sclerosis: The MSchannelomics project.
2014
Novel gating modulators of KCa3.1 channels and therapeutic perspectives
2016
NOVEL NEGATIVE GATING MODULATORS OF KCA2/3 POTASSIUM CHANNELS AS PHARMACOLOGICAL TOOLS FOR NOVEL TRATMENSTS
2014
Novel potent small molecule modulators of cardiac KCa2 and KCa3.1 channels: Potential utility for treating cardiac ischemia and atrial fibrillation.
2013
Novel potent small molecule modulators of coronary endothelial KCa2 and KCa3.1 channels
2013
Opening of TRPV4 channels induce relaxation mediated by KCa3.1 channels and nitric oxide synthase in mouse pulmonary arteries
2012
Páginas
1
2
siguiente ›
última »